subscribeSubscribe
PTC`s re-examination bid for Translarna falls short in Europe

PTC`s re-examination bid for Translarna falls short in Europe
FIERCE PHARMA
25 Jan 2024
Share Share
EMA recommends non-renewal of authorisation of medicine Translarna

EMA recommends non-renewal of authorisation of medicine Translarna
EMA
15 Sep 2023
Share Share
NICE signs off on rare disease therapies from Alnylam, PTC

NICE signs off on rare disease therapies from Alnylam, PTC
Zoey Becker FIERCE PHARMA
20 Jan 2023
Share Share
PTC to Present Clinical & Real-World Evidence on Translarna at Annual Congress

PTC to Present Clinical & Real-World Evidence on Translarna at Annual Congress
PRNEWSWIRE
11 Oct 2022
Share Share
Translarna not approved by NICE for DMD on NHS

Translarna not approved by NICE for DMD on NHS
PHARMAPHORUM
03 Oct 2022
Share Share
PTC Tx to Host Call to Review Topline Results from Study 041 for Translarna

PTC Tx to Host Call to Review Topline Results from Study 041 for Translarna
PRNEWSWIRE
20 Jun 2022
Share Share
ANVISA grants expanded approval to Translarna to include ambulatory patients

ANVISA grants expanded approval to Translarna to include ambulatory patients
PHARMABIZ
27 Oct 2021
Share Share
PTC Announces Expansion of Translarna™ Label to Include Ambulatory Patients

PTC Announces Expansion of Translarna™ Label to Include Ambulatory Patients
PRNEWSWIRE
25 Oct 2021
Share Share
STRIDE Data Show Translarna Delays Loss of Ambulation by More Than Five Years

STRIDE Data Show Translarna Delays Loss of Ambulation by More Than Five Years
PRNEWSWIRE
20 Sep 2021
Share Share
PTC aims again for FDA review of Duchenne drug despite latest miss

PTC aims again for FDA review of Duchenne drug despite latest miss
J. Gardner BIOPHARMADIVE
06 Feb 2021
Share Share